As the primary component of the amyloid plaques seen in the brains of Alzheimer patients, amyloid- (A) refers to peptides of 36–43 amino acids that are crucially involved in Alzheimer's disease. The amyloid precursor protein (APP), which is cut by specific enzymes to produce A, produces the peptides. Amyloid molecules can group together to create a variety of flexible, soluble oligomers.A amyloid-peptide buildup results from excessive A production or malfunctioning clearance mechanisms. Amyloid- forms diffuse and neuritic plaques in the parenchyma and blood vessels by self-aggregating into oligomers of various sizes. Strong synaptotoxins, proteasome inhibition, mitochondrial inhibition, alteration of intracellular Ca2+ levels, and induction of inflammatory processes are all characteristics of amyloid-oligomers and plaques. Neuronal dysfunction is also thought to be influenced by the loss of A's typical physiological functions.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V71438 | 2,3-Dehydrosilybin A | 25166-14-7 | 2,3-Dehydrosilybin A is a longevity-promoting and anti-aggregation compound. |
|
V71371 | 2-Hydroxy-5-(phenyldiazenyl)benzoic acid-d5 | 1331662-16-8 | 2-Hydroxy-5-(phenyldiazenyl)benzoic acid-d5 is deuterated labeled 2-Hydroxy-5-(phenyldiazenyl)benzoic acid. |
|
V104737 | 2002-G12 | 313666-93-2 | 2002-G12 (compound 5a) is an Aβ42 inhibitor that can reduce Aβ42 toxicity by 76%. |
|
V111853 | 4-Sulfocalix[4]arene | 112269-92-8 | 4-Sulfocalix[4]arene (p-sulfonocalix[n]arene) is an amyloid β42 (amyloid β42) binder with a Kd value of 5.39 M. |
|
V77650 | 5-FAM-β-Amyloid (1-42), human TFA (5-FAM-Amyloid β-peptide (1-42) (human) TFA) | 5-FAM-β-Amyloid (1-42), human (5-FAM-Amyloid β-peptide (1-42) (human) TFA is a 5-FAM-labeled β-Amyloid (1-42), human (TFA). | |
|
V86199 | 5-FAM-β-Amyloid (1-42), human Tris (5-FAM-Amyloid β-peptide (1-42) (human) Tris) | ||
|
V83543 | 6′-Methyl paeonol | 6540-66-5 | |
|
V71443 | 7-Deoxy-trans-dihydronarciclasine | 145987-74-2 | 7-Deoxy-trans-dihydronarciclasine is an alkaloid and an inhibitor (blocker/antagonist) of tobacco mosaic virus (TMV) (IC50= 1.80 μM). |
|
V71439 | [Ala28]-β Amyloid(25-35) (β(25-35)KA) | 173993-86-7 | [Ala28]-β Amyloid(25-35) (β(25-35)KA) is an electroneutral mutant peptide of Aβ(25-35) that accelerates the aggregation of firefly luciferase. |
|
V114718 | [Ala28]-β Amyloid(25-35) TFA | [Ala28]-β amyloid(25-35) (β(25-35)KA) TFA is an electronegative mutant peptide of Aβ(25-35) that can accelerate the aggregation of firefly luciferase. | |
|
V71378 | [Arg6]-β-Amyloid (1-40), england mutation | 1802084-26-9 | [Arg6]-β-Amyloid (1-40), england mutation is a biologically active peptide. |
|
V77472 | [Arg6]-β-Amyloid (1-42), england mutation | [Arg6]-β-Amyloid (1-42), england mutation is a biologically active peptide. | |
|
V71392 | [Asn23] β-Amyloid (1-40), Iowa mutation | 374796-72-2 | [Asn23] β-Amyloid (1-40), Iowa mutation is a biologically active peptide. |
|
V77473 | [Asn23]-beta-Amyloid (1-42), iowa mutation | [Asn23]-beta-Amyloid (1-42), iowa mutation is a biologically active peptide. | |
|
V92286 | [D-Ser14]-Humanin | 570382-85-3 | [D-Ser14]-Humanin is a biologically active peptide in which the Ser14 residue of humanin is changed from L-form to D-form. |
|
V113880 | AAKLVFF | 1038400-67-7 | AAKLVFF is an oligopeptide that can self-assemble into nanotubes. |
|
V118479 | ABri | 241145-90-4 | ABri is an amyloid subunit composed of 34 amino acids. It exhibits heterogeneity at both its N-terminus and C-terminus and has no sequence homology with any known amyloid protein. |
|
V71399 | AC 253 | 151804-79-4 | AC 253 is an antagonist of amylin, inhibiting 125I-adrenomedullin binding, with IC50 of 25 nM. |
|
V118560 | Ac-BIM-acid bromide | Ac-BIM-acid bromide is an acridine derivative that can significantly inhibit the fibrotic effects of amyloid protein. | |
|
V71397 | Acetly-β Amyloid(15-20), Amide | 189064-06-0 | Acetly-β Amyloid (15-20), Amide is a polypeptide fragment. |